U.S. Telecom Services and Carriers Stock News

In recent days, Pinterest reported growth in both monthly active users and revenue, alongside rapid advancements in its AI-powered product offerings and integration of shopping features. International markets are emerging as an important source of revenue upside for the company, with particularly strong performance seen in the "Rest of World" and Europe segments. We'll explore how Pinterest's evolving AI-driven shopping assistant capabilities could influence its investment outlook and...

Lattice Semiconductor (LSCC) jumped 4% following its latest earnings report, which matched expectations and emphasized strong customer demand in communications, data center, and AI infrastructure. Management’s upbeat guidance signals improving momentum after a market pullback. See our latest analysis for Lattice Semiconductor. Lattice’s strong earnings update and bullish outlook helped revive positive sentiment following a challenging stretch for the stock. After a dip earlier this year,...

Powell Industries (POWL) has attracted attention as investors assess recent performance trends and valuation in the current market landscape. The stock's movement highlights how the company is being compared with its past returns and sector peers. See our latest analysis for Powell Industries. It has been a dramatic run for Powell Industries, with the recent share price dropping sharply but longer-term total shareholder returns staying impressive. After a quick selloff, with an 11% share...

Amer Sports (NYSE:AS) delivered a clear earnings surprise in the third quarter, with sales and profit figures outpacing expectations and fueling a sharp stock rally. Management's upgraded outlook for 2025 adds another layer of interest for investors. See our latest analysis for Amer Sports. Amer Sports’ latest earnings beat has supercharged market enthusiasm, sending the share price up 20.5% year-to-date and fueling a one-year total shareholder return of 65.8%. Sustained growth from core...

Amicus Therapeutics (FOLD) has crossed an important threshold in Q3 2025 by reaching GAAP profitability, propelled by growing sales of its rare disease treatments Galafold and Pombiliti + Opfolda. This shift adds new context for investors. See our latest analysis for Amicus Therapeutics. After a challenging few years, Amicus Therapeutics’ recent GAAP profitability has been accompanied by a clear upswing in the stock’s momentum, with a 15.3% share price return over the past month and a notable...

Ever wondered if Analog Devices stock is actually worth its current price, or if the market might be missing something? Let’s break things down so you can judge for yourself. Over the past week, the share price dipped by 2.2%, but it is still up 9.9% year to date and 10.4% over the past 12 months, adding to a strong multi-year track record. Recent news coverage has highlighted continued optimism for the semiconductor sector, with analysts noting Analog Devices’ strong positioning in...

Beam Therapeutics (BEAM) is drawing attention following its latest updates on clinical progress in gene editing, a solid financial outlook, and visible milestones such as its recent scientific data presentation at a major healthcare conference. See our latest analysis for Beam Therapeutics. Despite ongoing progress in its clinical pipeline and a solid cash runway, Beam Therapeutics’ share price has seen some turbulence, declining by 31.5% over the last month. However, momentum has swung more...

NIO (NYSE:NIO) shares have trended lower over the past month, with the stock down nearly 19% in that span. Investors are watching closely for further updates as the electric vehicle market remains competitive and sentiment around Chinese automakers shifts. See our latest analysis for NIO. After a strong start to the year, with a year-to-date share price return of 26.37%, NIO’s recent momentum has faded as the stock has now slipped nearly 19% over the past month. Despite this short-term...

Triumph Financial has just announced an expanded collaboration with NFI, a major player in logistics. NFI is adopting Triumph’s Payment, Audit, and Intelligence solutions to further digitize and automate payments across its carrier operations. See our latest analysis for Triumph Financial. Triumph Financial’s expanded partnership with logistics giant NFI comes on the heels of a new $40 million shelf registration and its recent presentation at a high-profile investment conference. This is...

Wondering if UnitedHealth Group's stock is a bargain or perhaps a value trap? You're not alone. We are diving straight into the numbers to find out what the market might be missing. Despite its blue-chip reputation, the stock has seen sharp moves lately. It dropped 8.8% this week and has declined 38.7% year-to-date, with a substantial 47.4% decrease over the past 12 months. Investors have been on edge recently after several major healthcare providers reported shifting market conditions,...

Dynex Capital (DX) has been catching the eye of income-focused investors recently, particularly with its steady dividend profile and the company’s performance over the past year. Shares have climbed 26% in the past 12 months, reflecting renewed interest in the mortgage REIT sector. See our latest analysis for Dynex Capital. Dynex Capital's share price has steadily advanced over the past year, with most of that momentum coming in the last several months as investors warmed to the sector. While...

Bank of Hawaii (BOH) has seen shares fluctuate over the past week, with a small daily gain following modest losses earlier in the month. Investors may be watching for signs of stability amid shifting sentiment. See our latest analysis for Bank of Hawaii. After a choppy period, Bank of Hawaii's momentum has been mixed, with a recent recovery helping to offset prior weakness. Although the 1-year total shareholder return sits at -13.2% and the share price is still well below where it started the...

Roku (ROKU) shares are catching attention as investors weigh its recent performance and future prospects. Over the past month, the stock has slipped by 3%, despite showing a 2% uptick in the past 3 months. See our latest analysis for Roku. Zooming out, Roku’s one-year total shareholder return stands at 35.5%, reflecting building momentum even after a sharp one-week share price pullback. With solid YTD gains and resilient longer-term growth, investors seem to be reassessing Roku’s potential as...

Constellium (NYSE:CSTM) shares ended the week up slightly, gaining just under 1% on Friday. The company has shown steady performance recently, sparking some discussion among investors about where the stock could head next. See our latest analysis for Constellium. Constellium’s steady gains on Friday follow a robust year-to-date share price return of nearly 45%, a sign of momentum that stands out even after a recent pullback. Over the past year, total shareholder return reached 27.5%, making...

NVIDIA reported third quarter earnings for the period ended October 26, 2025, with revenue rising to US$57.01 billion and net income increasing to US$31.91 billion, while also issuing strong fourth-quarter revenue guidance and revealing a wave of new AI infrastructure partnerships including collaborations with HUMAIN, Microsoft, Anthropic, and Brookfield Asset Management. These announcements highlight a period of accelerated investment and adoption of NVIDIA’s AI platforms across cloud,...

Tradeweb Markets (TW) shares have seen some pressure lately, with the stock pulling back roughly 20% over the past three months. Investors are taking a closer look at the company’s long-term growth profile as market conditions shift. See our latest analysis for Tradeweb Markets. Tradeweb’s share price has lost momentum this year, with a 17% pullback over the past quarter and a year-to-date decline of 18.2%. Investors are digesting slower growth expectations and adjusting their risk appetite...

Lam Research Corporation recently announced its Board of Directors approved a quarterly dividend of $0.26 per share, to be paid on January 7, 2026, to shareholders of record as of December 3, 2025, and reported the results of its annual shareholder meeting, including a bylaw amendment and the outcome of a special meeting proposal vote. The announcement comes as Lam Research continues to experience strong demand for AI-driven semiconductor manufacturing equipment, which has shaped the...

Several law firms have recently filed securities class action lawsuits and launched investigations into Cytokinetics (CYTK), claiming that the company misled investors about regulatory timelines and risks associated with FDA approval of its drug aficamten. This wave of legal scrutiny follows earlier positive clinical data releases, which has sharpened investor focus on the company’s future disclosures and the broader regulatory process. See our latest analysis for Cytokinetics. Even as...

Four Corners Property Trust (FCPT) has just expanded its footprint, announcing the acquisition of a Caliber Collision property in Texas along with three Missouri automotive service sites. All properties are secured by long-term net leases, which supports FCPT’s ongoing growth strategy. See our latest analysis for Four Corners Property Trust. FCPT has been busy on the acquisition front this quarter, and that has coincided with a 1-year total shareholder return of -13.4%. While the company’s...

CyberArk Software (CYBR) shares have been on investors’ radar following recent trading activity. With the stock moving slightly over the past week and month, some are revisiting CyberArk’s long-term growth and ongoing performance trends to reassess its valuation. See our latest analysis for CyberArk Software. CyberArk’s momentum has cooled a bit recently, but its bigger picture remains bright. Despite a modest dip in the 1-day and 30-day share price returns, the stock’s year-to-date gain of...

Olema Pharmaceuticals (OLMA) shares jumped after Roche reported positive Phase 3 data for giredestrant, a breast cancer treatment in the same class as Olema’s investigational drug palazestrant. This announcement quickly drew market attention. See our latest analysis for Olema Pharmaceuticals. Momentum around Olema Pharmaceuticals has exploded, with the share price up 141% over the past week and a striking 250% in the past three months. Confidence is high thanks to Roche’s positive trial...

Bath & Body Works, Inc.'s ( NYSE:BBWI ) investors are due to receive a payment of $0.20 per share on 5th of December...

Atkore Inc. has announced its full-year financial results for the period ending September 30, 2025, reporting sales of US$2.85 billion, a decrease from US$3.20 billion the previous year, and moving from a net income of US$472.87 million to a net loss of US$15.18 million. This marks a significant shift in profitability and suggests heightened operational or demand-related pressures that could impact the company's near-term outlook. Given the swing from net income to net loss, we'll consider...

PG&E (PCG) stock has been in focus after recent share price declines, with many investors taking a closer look at the utility’s recent returns and business performance. The company’s stock is currently down compared to last year. See our latest analysis for PG&E. The latest share price pullback for PG&E, which now trades at $15.72, follows a challenging year marked by occasional regulatory headlines and persistent investor caution. Momentum has faded, as shown by the past week's 6.5% drop and...